Artificial Intelligence Approach to Early Detection of Breast and Cervical Cancers in Indian Patients.
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2024/04/065171
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient with diagnoses of carcinoma breast and carcinoma cervix
2.Willing to give consent for enrollment in the study.
4.Able to understand Hindi or English
5.Able to communicate properly
Exclusion Criteria
1. Unable to understand or answer a clinician-administered ESAS symptom questionnaire
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To develop and pilot an AI tool and its outcome to identify critical burdens of patients with breast and cervical cancers in Indian female patients on first visit and subsequent follow up visits.Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method To evaluate clinician experience with the tool and barriers and facilitators to the implementation of the tool and palliative care intervention.Timepoint: 12 months